Global Vitiligo Market, By Type (Segmental Vitiligo, Non-Segmental Vitiligo, Others), Treatment (Medications, Therapies, Surgery, Others), Dosage Form (Oral, Injectable, Creams, Gel, Ointment, Others), Route of Administration (Oral, Parenteral, Topical, Others), End-Users (Hospitals, Specialty Clinics, Homecare, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Others) – Industry Trends and Forecast to 2029
Market Analysis and Size
In recent years, the vitiligo market is anticipated to grow rapidly during the forecast period. Vitiligo is one of the 24 skin diseases listed by the American Academy of Dermatology Skin Disease. In 2013, more than 150,000 Americans of all ages were treated for vitiligo, at a cost of about USD 328 per patient, three times that of rosacea and double that of acne. Vitiligo is a skin disorder in which the pigmentation of the skin is lost in patches. Around the world, vitiligo affects 0.2 percent to 1% of the population. Vitiligo affects any part of the body when the skin's natural colour is lost due to a lack of melanin in the skin.
Data Bridge Market Research analyses that the Vitiligo market was valued at USD 1,127.12 million in 2021 and is expected to reach USD 1,837.54 million by 2029, registering a CAGR of 6.30% during the forecast period of 2022 to 2029. The market report curated by the Data Bridge Market Research team includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Market Definition
Vitiligo is a skin disorder in which colourless patches of skin develop. Vitiligo can affect the entire surface of the skin. This skin illness affects the eyes, the inside of the mouth, and the hair, and it differs from person to person. It's difficult to say how far the patches will expand and by how much. The emergence of white spots or patches on the skin is the most common symptom of vitiligo. Segmental vitiligo and non-segmental vitiligo are the two main kinds of vitiligo. Calcineurin inhibitors, corticosteroids, and psoralens are some of the most common medications prescribed by doctors to treat vitiligo.
Report Scope and Market Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2022 to 2029
|
|
Base Year
|
2021
|
|
Historic Years
|
2020 (Customizable to 2019 - 2014)
|
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Type (Segmental Vitiligo, Non-Segmental Vitiligo, Others), Treatment (Medications, Therapies, Surgery, Others), Dosage Form (Oral, Injectable, Creams, Gel, Ointment, Others), Route of Administration (Oral, Parenteral, Topical, Others), End-Users (Hospitals, Specialty Clinics, Homecare, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Others)
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America
|
|
Market Players Covered
|
F. Hoffmann-La Roche Ltd. (Switzerland), Mylan N.V. (US), Teva Pharmaceutical Industries Ltd. (Israel), Sanofi (France), Pfizer Inc. (US), GlaxoSmithKline plc (UK), Novartis AG (Switzerland), Zydus Cadila (India), AstraZeneca (UK), Johnson & Johnson (US), Bayer AG (Germany), Sun Pharmaceutical Industries Ltd. (India), Merck & Co., Inc. (US), Bristol-Myers Squibb Company (US), Eli Lilly and Company (US), Cipla Inc. (US), LEO Pharma A/S (Denmark), Aurobindo Pharma (India), Lupin (India), Hikma Pharmaceuticals PLC (UK)
|
|
Market Opportunities
|
|
Vitiligo Market Dynamics
Drivers
- Increasing prevalence of vitiligo
The rising prevalence of vitiligo is estimated to enhance the market's growth. Its prevalence rate ranges between 0.2% and 4%. Vitiligo is a hypopigmentation skin condition in which the skin loses its colour due to a lack of melanin in the skin cells. It affects all portions of the body's skin and the hair and the inside of the mouth. Vitiligo is a skin condition that is neither life-threatening nor communicable. It affects everyone, regardless of their skin type.
- Increasing investment for healthcare infrastructure
Another significant factor influencing the growth rate of vitiligo market is the rising healthcare expenditure which helps in improving its infrastructure. Also, various government organizations aims to improve the healthcare infrastructure by increasing funding and this will further influence the market dynamics.
Furthermore, rising initiatives by public and private organizations to spread awareness will expand the Vitiligo market. Additionally, changing lifestyles of people and rising level of disposable income will result in the expansion of Vitiligo market. The growing importance of aesthetic appeal and increased adoption of cosmetic procedures and other dermatology procedures will propel the market's growth rate.
Opportunities
- Increase in the number of research and development activities
Moreover, the market's growth is fueled by an increase in the number of research and development activities. This will provide beneficial opportunities for the Vitiligo market growth. Along with this, rising drug approvals and launches will further propel the market's growth rate.
Moreover, rising investment for the development of advanced technologies and increase in the number of emerging markets will further provide beneficial opportunities for the Vitiligo market growth during the forecast period.
Restraints/Challenges
On the other hand, high cost associated with the treatment will obstruct the growth rate of market. The dearth of skilled professionals and lack of healthcare infrastructure in developing economies will challenge the Vitiligo market. Additionally, complications involved with vitiligo such as psychological distress, eye problems, sunburn and hearing loss, and lack of awareness among people will act as restrain and further impede the growth rate of market during the forecast period of 2022-2029.
This vitiligo market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the Vitiligo market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Patient Epidemiology Analysis
Vitiligo market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analyses of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.
COVID-19 Impact on Vitiligo Market
Since its emergence in December 2019, the COVID-19 virus has spread to nearly every country on the planet, prompting the World Health Organization (WHO) to declare it a public health emergency. COVID-19, a new coronavirus, was identified as the causal agent in pneumonia cases. This virus spread quickly over the world, killing a large number of people. COVID-19 was labelled a global pandemic by the World Health Organization (WHO) in March 2020, and rigorous measures to prevent the disease's spread were recommended. Since then, the pandemic has delayed the expansion of the healthcare sector and disrupted the supply chain. Furthermore, governments in many nations had imposed nationwide lockdowns to halt the spread of COVID-19. Similarly, healthcare organizations in numerous nations throughout the world were having difficulty continuing their supply chain activities. The supply chain slowness hampered the vitiligo market.
Recent Development
- In October 2021, Uniza Group had announced the launch of a novel solution named Vitellus for the management of vitiligo. Vitellus is a unique combination of Greyverse, Melitane, GL 200 & EUK-134 which is considered an advanced new age solution for managing vitiligo. It is lotion that helps in melamine growth and functions on skin pigmentation and hair follicle pigmentation.
Global Vitiligo Market Scope
The Vitiligo market is segmented on the basis of type, treatment, dosage form, route of administration, end-users and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Type
- Segmental Vitiligo
- Non-Segmental Vitiligo
- Others
Treatment
- Medications
- Immunosuppressive
- Corticosteroids
Others
- Therapies
- Light Therapy
- Depigmentation
- Others
- Surgery
- Skin grafting
- Blister grafting
- Micropigmentation
- Others
- Others
Dosage Form
- Oral
- Injectable
- Creams
- Gel
- Ointment
- Others
Route of Administration
- Oral
- Parenteral
- Topical
- Others
End-Users
- Hospitals
- Specialty Clinics
- Homecare
- Others
Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
- Others
Vitiligo Market Regional Analysis/Insights
The vitiligo market is analysed and market size insights and trends are provided by country, type, treatment, dosage form, route of administration, end-users and distribution channel as referenced above.
The countries covered in the vitiligo market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America
North America dominates the vitiligo market because of the favourable reimbursement scenario and presence of major key players in this region. Additionally, rising healthcare expenditure will further propel the market's growth rate in this region.
Asia-Pacific is expected to grow during the forecast period due to the increasing number of cases of skin diseases due to sunlight exposure in this region. Also, development of healthcare infrastructure and rising awareness about the diseases will further propel the market's growth rate in this region.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Competitive Landscape and Vitiligo Market Share Analysis
The vitiligo market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to vitiligo market.
Some of the major players operating in the vitiligo market are:
- F. Hoffmann-La Roche Ltd. (Switzerland)
- Mylan N.V. (US)
- Teva Pharmaceutical Industries Ltd.(Israel)
- Sanofi (France)
- Pfizer Inc. (US)
- GlaxoSmithKline plc (UK)
- Novartis AG (Switzerland)
- Zydus Cadila (India)
- AstraZeneca (UK)
- Johnson & Johnson (US)
- Bayer AG (Germany)
- Sun Pharmaceutical Industries Ltd. (India)
- Bristol-Myers Squibb Company (US)
- Eli Lilly and Company (US)
- Cipla Inc. (US)
- LEO Pharma A/S (Denmark)
- Aurobindo Pharma (India)
- Lupin (India)
- Hikma Pharmaceuticals PLC (UK)
SKU-